Journal list Promote Sponsor
verified SJR 0,232 · Q3 • database Scopus / SJR & Latindex indexed
Drugs and Therapy Perspectives
United Kingdom · Adis International Ltd
workspace_premium Q3 — Pharmacology (medical) lock Subscription

Drugs and Therapy Perspectives

Drugs and Therapy Perspectives is a journal indexed in SJR in Pharmacology (medical) with an H index of 15. It has a price of 2480 €. It has an SJR impact factor of 0,232 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,232.

ISSN: 1172-0360
Publisher: Adis International Ltd
Category: Pharmacology (medical)
Indexation: verifiedScopus / SJR verifiedLatindex
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,232 Q3
H-index 15
Acceptance rate pie_chart
51%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.480 € Subscription
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Latindex

SJR Impact

0,232

H-index

15

Docs (year)

76

Docs 3y

216

Total refs

1769

Cites 3y

109

Citable 3y

205

Cites/Doc 2y

0.53

Ref/Doc

23.28

Immediate OA

2480 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs